Cantor Fitzgerald analyst Ross Osborn reiterated an Overweight rating and $2.00 price target on Lucid Diagnostics Inc (NASDAQ: LUCD) following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE